🇺🇸 FDA
Patent

US 10046010

Methods of generating mesenchymal stem cells which secrete neurotrophic factors

granted A61KA61K2035/124A61K35/28

Quick answer

US patent 10046010 (Methods of generating mesenchymal stem cells which secrete neurotrophic factors) held by BRAINSTORM CELL THERAPEUTICS LTD. expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BRAINSTORM CELL THERAPEUTICS LTD.
Grant date
Tue Aug 14 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2035/124, A61K35/28, A61P, A61P21/00